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The use of a suitable food carrier such as cheese could significantly enhance probiotic
viability during storage. The main goal of this study was to assess viability of commercial
probiotic strains during Cheddar cheesemaking and ripening (4–6 months) by comparing the
efficiency of microbiological and molecular approaches. Molecular methods such as quan-
titative PCR (qPCR) allow bacterial quantification, and DNA-blocking molecules such as
propidium monoazide (PMA) select only the living cells’ DNA. Cheese samples were man-
ufactured with a lactococci starter and with one of three probiotic strains (Bifidobacterium
animalis subsp. lactis BB-12, Lactobacillus rhamnosus RO011, or Lactobacillus helveticus
RO052) or a mixed culture containing B. animalis subsp. lactis BB-12 and L. helveticus
RO052 (MC1), both lactobacilli strains (MC2), or all three strains (MC3). DNA extractions
were then carried out on PMA-treated and non-treated cell pellets in order to assess PMA
treatment efficiency, followed by quantification using the 16S rRNA gene, the elongation
factorTu gene (tuf ) or the transaldolase gene (tal ). Results with intact/dead ratios of bacteria
showed that PMA-treated cheese samples had a significantly lower bacterial count than
non-treated DNA samples (P <0.005), confirming that PMA did eliminate dead bacteria
from PCR quantification. For both quantification methods, the addition of probiotic strains
seemed to accelerate the loss of lactococci viability in comparison to control cheese sam-
ples, especially when L. helveticus RO052 was added. Viability of all three probiotic strains
was also significantly reduced in mixed culture cheese samples (P <0.0001), B. animalis
subsp. lactis BB-12 being the most sensitive to the presence of other strains. However,
all probiotic strains did retain their viability (log 9 cfu/g of cheese) throughout ripening.This
study was successful in monitoring living probiotic species in Cheddar cheese samples
through PMA-qPCR.
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INTRODUCTION
A minimum of 107 cfu/mL or g and even higher numbers such
as 108 and 109 cfu per daily portion of probiotic bacteria must
be present in a product to retain their health benefits (Gomes da
Cruz et al., 2009; Bhadoria and Mahapatra, 2011; Karimi et al.,
2011). The use of an appropriate food carrier is thought to help
promote bacterial viability and stability during storage (Roy and
Delcenserie, 2011). Probiotic Cheddar cheese has already been
successfully manufactured for this purpose (Daigle et al., 1999;
Phillips et al., 2006; Ong et al., 2007) and suitable probiotic bacteria
should be carefully chosen for this type of delivery vehicle.
As lactobacilli species are naturally found in this type of cheese
and are resistant to acid production during cheese manufacture,
some strains of Lactobacillus acidophilus, Lactobacillus casei, Lac-
tobacillus rhamnosus, and Lactobacillus plantarum have a techno-
logical advantage for use as probiotics. Among the bifidobacteria
in use, Bifidobacterium animalis subsp. lactis BB-12 is an espe-
cially acid resistant and aerotolerant strain, making it suitable for
applications in such a food matrix (Roy et al., 2011). As each
strain has their own technological properties and possesses specific
health benefits (Roy, 2011), a combination of strains could also
enhance the health value of the product (Temmerman et al., 2004).
Furthermore, interactions between probiotic strains, but also with
the lactococci Cheddar cheese starter, could affect bacterial viabil-
ity in cheese samples (Gomes and Malcata, 1999; Ong et al., 2007).
Probiotic viability is usually monitored with traditional
culture-dependent methods, which are both time consuming and
imprecise. They can underestimate microbial counts and not
detect viable but non-cultivable (VBNC) bacteria or lack speci-
ficity, especially for the closely related lactic acid bacteria found in
cheese (García-Cayuela et al., 2009; Ndoye et al., 2011). Bacterial
quantification is now possible through quantitative PCR (qPCR).
DNA can be detected even after cell death, which makes RNA the
better choice to study bacterial viability (Ndoye et al., 2011), except
that RNA is extremely fragile and necessitates an additional step of
retrotranscription to cDNA before further analysis. To avoid these
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problems, DNA can be used to study viability as long as its amplifi-
cation in dead cells is blocked. Propidium monoazide (PMA) can
now be used for this purpose (Nocker and Camper, 2006, 2009),
but has never been used in cheese samples.
The aim of this study was to analyze probiotic viability during
Cheddar cheese manufacture and ripening using a combination
of qPCR and PMA-qPCR. Two strains of lactobacilli (Lactobacil-
lus helveticus RO052 and L. rhamnosus RO011) and one strain
of bifidobacteria (B. animalis subsp. lactis BB-12) were studied in
single and mixed cultures. PMA-qPCR is optimized for cheese and
its efficiency is compared with traditional culture media selective
for each species.
MATERIALS AND METHODS
BACTERIAL STRAINS
Lactobacillus helveticus RO052 and L. rhamnosus RO011 were
obtained in lyophilized or frozen form, respectively, from the
Rosell-Lallemand Institute (Montreal,QC,Canada). Toxicity stud-
ies for these two strains have been completed and no toxicity was
observed (Foster et al., 2011). B. animalis subsp. lactis BB-12 was
obtained from Chr. Hansen (Hørsholm, Denmark) in frozen form.
This culture, which has been used for over 25 years in fermented
dairy products, has been classified as GRAS (Generally Recognized
As Safe) by the FDA (Rulis, 2002) and approved by the Danish
Medicines Agency as a Natural Health Product. The lactococci
starter 970 (also in frozen form) was obtained from Fromagex
(Rimouski, QC, Canada). All other bacterial species used for qPCR
probe and primer specificity assessment were either obtained from
the NCIMB collection (National Collection of Industrial, Marine
and Food Bacteria, UK), the American Type Culture Collection
(ATCC, Manassas, VA, USA), or were isolated from Canadian
Cheddar cheese samples (Table 1).
CHEESEMAKING PROCEDURES AND CHEMICAL ANALYSIS
Experimental Cheddar cheese samples were manufactured follow-
ing standard procedures (Kosikowski, 1977) in 10 L vats (INRA,
Poligny, France). Briefly, whole milk was obtained from the
Deschambault Animal Sciences Research Center and treated the
same day by high temperature short time (HTST) pasteuriza-
tion, followed by cooling at 32˚C. Four repetitions of each type
of cheese were randomly made for the first experiment, and
three were made for the second experiment. The purpose of the
first experiment was to optimize the quantification methods, and
the cheese samples were manufactured with a 0.03% inoculation
(based on microbiological counts) of the lactococci starter cul-
ture (starter 970 from Fromagex) and with a single culture of
probiotic (RO052, RO011, or BB-12) inoculated after 5 min at
an appropriate concentration to reach log 8 cfu/g of cheese before
ripening (0.01% inoculation for RO052 and BB-12 and 0.0143%
inoculation for RO011). The control cheese did not contain any
probiotic adjunct (CTL). For the second experiment, inoculations
were adjusted to higher levels to match traditional cheesemak-
ing standards for lactococci starters (0.3% inoculation to reach
log 9 cfu/g of cheese before ripening and Health Canada guide-
lines for probiotic consumption (0.1% inoculation for RO052 and
BB-12 and 0.143% inoculation for RO011 to reach log 9 cfu/30 g
portion of cheese before ripening). These cheese samples were
manufactured with one to three probiotic strains [BB-12+RO052
(MC1), RO011+RO052 (MC2), BB-12+RO011+RO052 (MC3)],
and included a control cheese without probiotics (MC0). A CaCl2
solution (0.02% v/v) was added, as was veal rennet (0.02% v/v; Fro-
magex), when the milk acidity had increased by 4.0˚Dornic. When
coagulation was achieved, the curd was cut and heated to 38˚C,
followed by whey draining and cheddaring. The resulting cheese
was cut, salted (2.0% w/w) and pressed overnight to produce 1 kg
blocks, which were then vacuum-packed in plastic bags and stored
at 4˚C. Microbiological and molecular analyses were conducted on
samples taken after the initial probiotic inoculation, after cooking,
after cheddaring, after salting, and after pressing. During ripen-
ing, new cheese samples were analyzed every month for a total
of 4 (for samples MC0, MC1, MC2, and MC3) to 6 months (for
samples CTL, BB-12, RO011, and RO052).
Table 1 | Genomic DNA and 16S rDNA, tuf and tal sequences used for primer design and testing.
Bacterial species and strain Reference/source 16S rDNA gene
accession number
tuf accession
number
tal accession
number
Lactococcus lactis subsp. cremoris SK11 Marakova et al. (2006) 4434136 4433356 4434063
Lactococcus lactis subsp. lactis IL1403 Bolotin et al. (2001) 1115962 1113987 1114937
Bifidobacterium animalis subsp. lactis BB-12 Chr. Hansen GU116483 GQ302843 FJ357031
Lactobacillus helveticus RO052 Rosell-Lallemand Institute DQ123580 DQ123584 NA**
Lactobacillus rhamnosus RO011 Rosell-Lallemand Institute RO011_ r07923 RO011_02150 RO011_05652
Lactobacillus casei ATCC 334 Marakova et al. (2006) 4421666 4421117 4420558
Lactobacillus parabuchneri Experimental Cheddar cheese JQ247532* NA** NA**
Lactobacillus brevis Experimental Cheddar cheese JQ247531* NA** NA**
Lactobacillus coryniformis Experimental Cheddar cheese JQ247530* NA** NA**
Lactobacillus curvatus Canadian commercial Cheddar cheese JQ247525* NA** NA**
Lactobacillus plantarum ATCC 14917 American type culture collection AF080101 NA** NA**
Lactobacillus zeae ATCC 15820 American type culture collection AB008213 NA** NA**
*Submitted to GenBank after partial 16S rDNA gene sequencing to confirm identification.
**NA, no sequence available (DNA used to verify amplification efficiency).
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Total titratable acidity was measured at all cheesemaking stages
using an automatic titrator (Sigma-Aldrich, Oakville, ON, Canada;
data not shown) along with pH, and final pH of the cheese samples
was also measured. All other chemical analyses were conducted
on cheese samples after 7 days. Fat content was analyzed follow-
ing the Mojonnier extraction method (Atherton and Newlander,
1977), and protein content, with the Dumas nitrogen combustion
method (Wiles et al., 1998). Final humidity was calculated from
dry matter determination, and salt content was calculated with
Quantab strips (Quantab, Hach, Loveland, CO, USA). Sugar and
organic acid concentrations were obtained through HPLC analy-
sis (HPLC Waters 600, Waters Corp, Milford, MA, USA) using
an ION-300 column (Transgenomic Inc., Omaha, NE, USA) with
a mobile H2SO4 phase (0.02 N) and a 0.4 mL/min flow rate for
chromatographic separation.
BACTERIAL ISOLATION FROM CHEESE SAMPLES
Ten grams of cheese were mixed with 90 mL of sterile 2% trisodium
citrate (2% w/v) and homogenized with the Stomacher® 400 Cir-
culator (Seward,Worthing,West Sussex, UK) for 5 min at 230 rpm,
two 1 mL samples of the resulting suspension were used, one for
microbiological counts and the other for DNA extraction after
PMA treatment.
BACTERIAL ENUMERATION USING MICROBIOLOGICAL COUNTS
One milliliter of homogenized cheese suspension was serially
diluted in 9 mL of sterile peptone water (0.1%) acidified with
cysteine (0.05%) and adjusted to a final pH of 6.8. For all three
probiotic strains, the MRS culture medium (Fluka, Saint-Louis,
MO, USA) was used in combination with a specific antibiotic for
each strain. RO052 was grown on MRS agar containing 5 mg/L of
ciprofloxacin (Fluka) and incubated in anaerobic jars for 72 h at
37˚C. For RO011, 100 mg/L of vancomycin (EMD, USA) was used,
and plates were incubated aerobically for 72 h at 43˚C. Finally,
50 mg/L of mupirocin (Sigma, Saint-Louis, MO, USA) was used
for BB-12 selection, and all plates were incubated at 37˚C for 72 h
in anaerobic jars. The M17 culture medium (Difco Laboratories,
Detroit, MI, USA) was used for lactococci enumeration and incu-
bated aerobically at 30˚C for 48 h. Additionally, routine quality
controls for total mesophilic and psychrotrophic bacteria (Plate
Count Agar, EMD Millipore Corporation, Billerica, MA, USA),
coliforms (Coliform plate 50, 3M, London, ON, Canada), and
staphylococci (Baird Parker Agar, Oxoid, Hampshire, United King-
dom) were carried out on raw and pasteurized milk and on the
fresh cheese samples (day one; data not shown).
PROPIDIUMMONOAZIDE TREATMENT
Bacterial suspensions were treated with PMA according to the
procedure developed by Nocker and Camper (2006) with the fol-
lowing modifications made for cheese samples. One milliliter of
the cheese suspension was centrifuged at 10,000×g for 20 min, and
the fat layer was removed with sterile swabs before the cell pellet
was suspended in 500µL of a TE 2X solution (20 mM Tris HCl pH
8.0, 2 mM EDTA). The PMA powder (phenanthridium, 3-amino-
8-azido-5-[3-(diethylmethylammonio) propyl]-6-phenyl dichlo-
ride, Biotium Inc., Hayward, CA, USA) was initially dissolved in
20% dimethyl sulfoxide (DMSO) to reach a final concentration
of 20 mM and stored at −20˚C. For each bacterial suspension,
1.25µL of the PMA was added (final concentration of 50µM),
and the tubes were shaken in the dark for 5 min to allow for maxi-
mal PMA contact with DNA. Then, all tubes were placed in a PMA
lamp apparatus (halogen 500 W, Ingenia Biosystems, Barcelona,
Spain) for 15 min. The PMA-treated cell suspensions were then
centrifuged at 10,000×g for 15 min to recover cell pellets for DNA
extraction and stored at−20˚C.
DNA EXTRACTION
Total genomic DNA from cheese samples was obtained following
the protocol from Licitra et al. (2007). Briefly, the DNeasy Blood
and Tissue kit with the Gram positive bacteria DNA extraction
protocol (Qiagen, Mississauga, ON, Canada) was used with the fol-
lowing modifications. Bacterial pellets were suspended in 180µL
(for pure cultures) or 400µL (for cheese samples) of buffer for
enzymatic lysis [20 mM Tris HCl pH 8.0, 2 mM EDTA, 1.2% Triton
X-100, 20 mg/mL lysozyme (Sigma-Aldrich), 10µL/ml of 5 U/mL
mutanolysin (Sigma-Aldrich)] and incubated at 37˚C for 1 h. Pro-
tein digestion was performed by adding 25µL of proteinase K
and 200µL of AL buffer from the DNeasy Blood and Tissue kit
(Qiagen) and incubating at 70˚C for 30 min. The suspensions were
then transferred to a 2 mL microtube containing 0.3 g of zirconium
beads (1 mm diameter, Biospec Products, Bartlesville, OK, USA).
Tubes were shaken twice for 90 s in a Mini-Beadbeater-16 (Biospec
Products) and then centrifuged at 10,000×g for 10 min at room
temperature. Finally, the nucleic acids were precipitated from the
supernatant by adding 200µL of ice-cold absolute ethanol. DNA
purification was performed as specified in Qiagen’s instructions.
Residual RNA was removed using DNAse free RNase (Roche,Laval,
QC, Canada) according to the manufacturer’s instructions. DNA
samples were stored at−20˚C.
QUANTIFICATION OF BACTERIAL VIABILITY IN PMA-TREATED
SAMPLES
Primer and probe design for probiotic and lactococci detection
Primers for the 16S rRNA gene were designed for total lactococci,
as well as for the elongation factor Tu gene (tuf) for L. helveticus
and L. rhamnosus and for the transaldolase gene (tal) for B. ani-
malis subsp. lactis (Table 2). For L. rhamnosus, a specific TaqMan®
probe was also designed for the tuf gene. Gene sequences for dif-
ferent Bifidobacterium sp., lactobacilli, and lactococci species were
obtained from GenBank (Table 1) and aligned using Clustal W
multiple sequence alignment software. Primers were manually
designed using Primer Express software v. 2.0 (Applied Biosys-
tems) using the sequence region with highest homology within the
same species, but with high divergence between species. The PCR
amplification was then simulated1, and specificity was verified
in silico by BLASTN2. All primers were also tested for hairpins and
primer dimers using the Oligo analyzer software 3.1 (Integrated
DNA Technology).
Verification of primer specificity by quantitative PCR
The specificity of each primer pair to the targeted species was
determined by qPCR against the genomic DNA of lactococci,
lactobacilli, and bifidobacteria species, along with other LAB
1http://insilico.ehu.es/PCR/
2http://blast.ncbi.nlm.nih.gov/
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Table 2 | qPCR primers, efficiency, and detection limits for all bacterial species.
Bacterial species
(selected gene)
Primers and probes* Amplicon
length
(bp)
Concen-
tration
(µM/µL)
Slope Intercept
point
Efficiency
(%)
R2 Range
(copy
number)
Detection
limit
(log cfu/g)
Lactococcus sp.
(rDNA 16S)
F: 5′-GAGGCAGCAGTAGGGAATCTTC-3′ 133 0.5 −3.4 44.9 99.4 0.99 104–1011 5.0
R: 5′-CTTGATGAGCTTTCCACTCTCA-3′ 0.5
L. helveticus (tuf) F: 5′-TTACAAGGCGACAAGGAAGC-3′ 158 0.8 −3.3 41.3 101.9 0.99 103–108 5.0
R: 5′-CGACCTGAAGCAACAGTACC-3′ 0.4
L. rhamnosus
(tuf)
F: 5′-CATGGCCCAATGCCACAA-3′ 70 0.9 −3.3 45.5 99.9 0.99 103–108 5.9
R: 5′-CAACGATGTATTCAACACCAACTT-3′ 0.9
P:5′-CACGTGAACATATTCTGTTTGGCGCGT-3′ 0.9
B. animalis
subsp. lactis (tal)
F: 5′-GCGCTGGGCTGCTCTGGAAGC-3′ 116 0.8 −3.3 46.3 99.6 0.99 104–109 5.0
R: 5′-TGGCGAGCTCATCGACATACT-3′ 0.4
*F, forward primer; R, reverse primer; P, probe.
species commonly found in Cheddar cheese (Table 1). Each 20µL
PCR amplification contained 10µL of Fast SYBR Green PCR Mas-
ter Mix (or TaqMan 2X Master Mix, Applied Biosystems, for L.
rhamnosus), 1µL of DNA (50 ng/µL), and an optimized concen-
tration of each primer (and probe for L. rhamnosus; Table 2).
After SYBR Green amplification, a dissociation curve analysis was
performed by increasing the temperature by 1˚C every 20 s from
65 to 94˚C to confirm the absence of non-specific amplification
products.
Determination of PMA treatment efficiency
In order to confirm that PMA-qPCR only quantified viable cells,
each bacterial species in defined dead to live cell ratio were quanti-
fied in pure culture and spiked into 1 g of sterilized cheese sample.
Dead cells were obtained following the protocol by Taskin et al.
(2011), either by heating cell suspensions to 100˚C for 18 min
in peptone water (for lactococci and RO011) or by adding iso-
propanol (for RO052 and BB-12) according to preliminary testing
which indicated the best method and the adequate time period
to kill the cells of each species without inducing DNA degrada-
tion. This experiment was carried out in duplicate. After PMA
treatment, DNA was then extracted following the same protocol
as the other cheese samples. qPCR amplifications were carried
out in triplicate, and C t results were then plotted against the
corresponding microbiological count (cfu/g).
Detection limit and standard curves
To evaluate the detection limit of the PMA-qPCR protocol, ser-
ial dilutions (from 1010 to 104 cfu/mL) of each bacterial species
were spiked into 1 g of sterilized cheese sample and treated with
PMA. DNA was then extracted following the same protocol as the
experimental cheese samples. For the standard curves, the DNA
from the highest bacterial concentration was serially diluted in
nuclease-free water. qPCR amplifications were carried out in trip-
licate, and C t results were then plotted against the corresponding
microbiological count (cfu/g).
Quantitative PCR amplifications
Quantitative PCR assays were carried out in 96-well plates and per-
formed in triplicate using an ABI PRISM 7500 Fast real-time PCR
system with software version 2.0.1 (Applied Biosystems). Each
20µL PCR amplification with SYBR Green primers contained
10µL of Fast SYBR Green PCR Master Mix (Applied Biosystems),
1µL of DNA, and an optimized concentration for each primer
(Table 2). For RO011 quantification, 10µL of the TaqMan 2X
Master Mix (Applied Biosystems) were used, and 1µL of the probe
was added. A positive control of DNA (not treated with PMA) for
each species and a no-template control (NTC) was included on
each plate. Amplification consisted of a 20 s denaturation step at
95˚C, followed by 40 two-step cycles of 3 s for 95˚C and 30 s at 60˚C.
After amplification with the SYBR Green Master Mix, a dissoci-
ation curve analysis was performed. The cycle threshold of each
sample was then compared to the corresponding PMA-treated
DNA standard curve.
STATISTICAL ANALYSIS
Statistical analyses on viable counts and qPCR results were per-
formed using the JMP9 Software (SAS Institute Inc). The Mixed
procedure was conducted with a full factorial design (variance
components covariance structure) with cheesemaking step, ripen-
ing time and single or mixed culture as fixed effects, and replicate
cheese blocks as the random classification variable. When results
were significantly different, a pairwise comparison of all means
was done using the Tukey–Kramer HSD test.
RESULTS
OPTIMIZATION OF PMA-qPCR FOR CHEESE
Cross amplification for primer and probe specificity
For all primer and probe sets designed to be specific for each
targeted bacterial species (Lactococcus sp., L. helveticus RO052, L.
rhamnosus RO011, and B. animalis subsp. lactis BB-12), C t val-
ues for targeted DNA were between 17 and 21, and non-targeted
DNA C t values were always above 30 with no cross amplifica-
tion (Table 3). Melting curves of amplicons only displayed one
peak, also indicating specific amplification for each primer and
probe set.
Quantitative PCR efficiency and detection limits
For qPCR, efficiencies for all primer and probe sets were between
99.4 and 101.9% with R2 values over 99% for all standard curves
which covered at least six dilutions (Table 2). As for the detection
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Table 3 | Specificity of primers and probe (C t results) for gene quantification.
Bacterial species and strain* Lactococcus sp.
(rDNA 16S)
L. helveticus
RO052 (tuf)
L. rhamnosus
RO011 (tuf)
B. animalis subsp. lactis
BB-12 (tal)
Lactococcus lactis subsp. cremoris SK11 17 36 35 40
Lactococcus lactis subsp. lactis IL1403 18 36 36 40
Bifidobacterium animalis subsp. lactis BB-12 38 35 35 18
Lactobacillus helveticus RO052 38 21 31 33
Lactobacillus rhamnosus RO011 37 35 17 35
Lactobacillus casei ATCC 334 36 35 30 35
Lactobacillus parabuchneri 35 36 34 33
Lactobacillus brevis 36 36 35 35
Lactobacillus coryniformis 39 36 36 40
Lactobacillus curvatus 38 35 35 35
Lactobacillus plantarum ATCC 14917 36 34 36 34
Lactobacillus zeae ATCC 15820 37 34 33 33
SeeTable 1 for GenBank accession numbers. Specific targeted DNA results are shown in bold letters.
limit in cheese samples (obtained by spiking), it was between
5 to 6 log cfu/g for all primer and probe sets, with the lowest
value for Lactococcus sp., B. animalis subsp. lactis, and L. helveti-
cus (5.0 log cfu/g) and the highest for L. rhamnosus (5.9 log cfu/g;
Table 2).
Determination of propidium monoazide efficiency for viable cell
quantification
In order to assess PMA efficiency in detecting only living cells and
for blocking the quantification of dead cells, viable to dead cell
ratios were obtained from pure cultures or spiked cheese samples
and were submitted to qPCR with or without prior PMA treat-
ment (Table 4). No significant difference was observed between
results obtained from pure cultures or spiked cheese samples
(P = 0.7062 for Lactococcus sp., P = 0.5352 for RO011, P = 0.3793
for RO052, and P = 0.1682 for BB-12), and quantification results
decreased significantly with lower viable to killed cell ratios for
PMA-treated samples (P = 0.0182 for Lactococcus sp., P = 0.0158
for RO011, P = 0.0149 for RO052, and P = 0.0091 for BB-12). For
unblocked DNA samples (results obtained with no PMA treat-
ment), quantification remained stable for all ratios with a slight
but non-significant decrease for Lactococcus sp. and RO011 with
lower viable to killed cell ratios.
QUANTIFICATION OF VIABILITY
Cultivable and viable cells were quantified with selective culture
media and qPCR coupled with PMA (Tables 5 and 6). For Lac-
tococcus sp. (Table 5), cultivable counts showed a one to two
log increase until the cheddaring and salting stages, reaching
log 9 cfu/g of cheese when probiotics were added in single culture,
and log 10 cfu/g of cheese when they were added in mixed cul-
ture. Cultivable lactococcal counts then decreased up to six logs
with ripening time (P < 0.0001) with significantly different results
between cheese samples (P < 0.0001), the lowest viable counts
being obtained in samples containing RO052 in single culture or
combined with RO011 (MC2) or all three probiotic strains (MC3).
PMA-qPCR results for all species produced significantly higher
viable counts than cultivable counts obtained with culture media
(P < 0.0001) as they reached log 12 cfu/g of cheese for lactococci
during manufacture (Table 5). Viable counts did not decrease as
much as cultivable counts with ripening time (P < 0.0001), as only
a two to three log cfu/g of cheese decrease was observed, particu-
larly when RO052 was added in single culture, but not when it was
added in mixed culture.
For probiotic strain viability (Table 6), no significant differ-
ence was found between mixed probiotic strain cheese samples.
Using selective culture media, a one log increase in cfu/g of cheese
was detected during cheesemaking, followed by a stabilization of
cultivable counts during ripening for all species. Viable counts by
PMA-qPCR were significantly lower than cultivable cell counts
obtained with specific culture media at the inoculation point
(P < 0.0001 for RO011, P = 0.0007 for RO052, and P < 0.0001
for BB-12), but reached higher levels afterward and were up to
one log cfu/g cheese higher at the end of ripening (Table 6). All
three probiotic strains appeared stable in all cheese samples during
ripening.
CHEMICAL COMPOSITION OF THE CHEESE SAMPLES
Final pH, moisture level, fat and protein content, as well as salt, glu-
cose and lactic acid concentration were not significantly different
between cheese samples of the same batch (made either with one
probiotic strain or with a mixed probiotic culture; Table 7). How-
ever, salt-to-moisture ratios were significantly higher for cheese
samples made with both lactobacilli strains (MC2; P = 0.0136),
and acetic acid and galactose concentrations were significantly
different between samples (P < 0.0001).
DISCUSSION
In fermented food products such as cheese, synergy between all
bacterial species present must be maintained without any negative
effect of probiotic addition on product quality, especially when
more than one probiotic strain is used. The impact of the bac-
terial ecosystem and the cheese environmental conditions (pH,
Aw, redox potential, and nutrient availability) on probiotic strains
must also be verified (Champagne et al., 2005; Saarela et al., 2006).
The aim of this study was to assess the viability of three probiotic
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Table 4 | Effect of propidium monoazide (PMA) on PCR quantification of defined ratios of viable to killed cells in pure culture or in Cheddar
cheese samples.
Bacterial species and strains Viable to killed cell ratio (%) Pure culture (log cfu/g) Cheddar cheese samples
(log cfu/g)
Without PMA With PMA Without PMA With PMA
Lactococcus sp. 100 9.6±1.7* 9.5±0.9 9.7±2.1 9.6±1.7
10 9.5±1.8 8.8±0.2 8.9±0.2 8.7±0.1
1 9.2±0.7 7.8±0.1 9.0±0.2 7.7±0.1
0.1 9.1±0.6 6.9±0.1 9.3±0.1 6.6±0.1
L. helveticus RO052 100 8.8±0.1 8.9±0.2 8.9±0.1 8.7±0.1
50 8.9±0.0 8.3±0.1 9.0±0.1 8.5±0.1
10 8.8±0.2 7.5±0.1 9.2±0.6 7.5±0.1
5 8.7±0.1 7.2±0.1 9.0±0.4 7.2±0.1
1 8.9±0.0 7.0±0.2 8.8±0.1 6.8±0.1
L. rhamnosus RO011 100 8.7±0.7 8.9±0.7 8.9±1.9 8.8±0.1
50 8.6±0.7 8.7±2.1 8.8±1.8 8.3±0.3
10 8.5±0.6 8.3±0.8 8.3±0.1 8.0±0.2
5 8.5±1.2 8.1±0.4 8.4±0.7 7.9±0.3
1 8.2±0.3 7.5±0.1 8.1±0.2 7.7±0.1
B. animalis subsp. lactis BB-12 100 9.5±0.1 9.7±0.1 9.4±0.1 9.5±0.1
50 9.5±0.1 9.2±0.5 9.4±0.1 9.1±0.3
10 9.8±1.8 8.6±0.2 9.4±0.1 8.5±0.1
5 9.8±0.9 8.4±0.1 9.6±0.8 8.0±0.1
1 9.7±1.6 7.8±0.2 9.6±0.1 7.7±0.2
*All results are expressed as mean values followed by their standard deviation (SD).
strains added in single or mixed culture in Cheddar cheese sam-
ples ripened for up to 6 months by comparing the efficiency of
microbiological and molecular approaches.
The selective culture media used for this study were specific to
each species, but their analysis was very time consuming and do
not correctly estimate viable cell counts during cheese ripening as
the antibiotics created restrictive culture conditions (Rawsthorne
and Phister, 2009). Also, some cells may be in an uncultivable state
while still contributing enzymatic activities (Lahtinen et al., 2006;
Coutard et al., 2007). The use of PMA-qPCR is better suited to
quantify total cellular viability (Kramer et al., 2009; Nocker and
Camper, 2009) and was optimized to work in Cheddar cheese sam-
ples, as DNA from dead cells was efficiently blocked by the PMA
molecules. PMA-qPCR has already been used to quantify probi-
otics in yogurt (García-Cayuela et al., 2009), but has not been used
in cheese to date.
In this study, lactococci from the starter culture decreased faster
during ripening when probiotic strains were present, especially
when L. helveticus RO052 was added. The presence of a combi-
nation of strains did not cause a greater reduction in viable lac-
tococci counts than single strains. This could be explained by the
lower pH values and concomitant non-dissociated organic acids
in cheese samples containing probiotics, although no significant
pH difference was found. Cultivable counts using culture media
greatly underestimated total lactococci viability when compared to
PMA-qPCR results, indicating the presence of many VBNC cells
in ripening Cheddar cheese which can only be detected by using
molecular methods. Dolci et al. (2010) also detected dominant
lactococci in cheese samples using DNA analysis, although they
were not detected in such numbers with microbiological meth-
ods. Rantsiou et al. (2008) and Flórez et al. (2006) proposed that
the presence of active lactococci throughout cheese ripening was
higher than previously believed. These bacteria can still maintain
their metabolic activity even though they cannot be cultivated and
can therefore contribute to the development of Cheddar cheese
texture and flavor during ripening (Ndoye et al., 2011).
The probiotic strains were chosen for their commercial use in
fermented food products such as cheese and yogurt, L. helveticus
RO052 and L. rhamnosus RO011 originating from dairy products
(Hagen et al., 2010; Foster et al., 2011). Both strains are resistant
to acidic pH levels (Dimitrov et al., 2005; Succi et al., 2005) which
are known to negatively affect probiotic viability, especially during
dairy product storage (Champagne et al., 2005). They also have a
higher tolerance to bile salts (Kheadr, 2006) and have been found
in the intestine after ingestion (Verdu et al., 2008), supporting the
requisite attributes for a probiotic strain. B. animalis subsp. lactis
BB-12 has also been widely studied and used in various probiotic
food products because of its resistance to higher acidity levels and
its greater oxygen tolerance (Lee and O’Sullivan, 2010).
In this study, all probiotic strains in mixed culture cheese sam-
ples remained at a 109 cfu/g level throughout ripening according
to viable counts obtained by selective culture media, a level which
is thought to be sufficient to offer a health benefit (Karimi et al.,
2011). Cheese is already known as an efficient food carrier for
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Table 7 | Chemical composition of each cheese sample after 14 days of ripening at 4˚C.
Component Cheese sample
†
CTL BB-12 RO011 RO052 MCO MCI MC2 MC3
Final pH 5.2±0.1a* 5.1±0.13a 5.2±0.2a 5.1±0.2a 5.3±0.1x 5.2±0.2x 5.2±0.2x 5.3±0.1x
Fat (%) 29.2±4.6a 26.6±3.6a 29.0±4.9a 30.8±3.2a 33.7±3.9x 33.5±4.6x 33.3±4.2x 33.0±4.2x
Moisture (%) 40.1±0.6a 39.8±1.5a 39.5±1.8a 39.6±0.7a 41.2±0.7x 43.7±7.9x 38.8±1.7x 44.5±9.6x
Salt (%) 1.3±0.1a 1.3±0.08a 1.3±0.1a 1.2±0.2a 1.4±0.07x 1.5±0.3x 1.9±0.5x 1.8±0.1x
Salt-to-moisture (%) 3.2±0.3a 3.2±0.2a 3.3±0.3a 3.2±0.6a 3.3±0.8x 3.4±0.5x 4.9±0.4x 3.9±0.7x
Protein (%) 22.6±0.3a 22.3±0.4a 22.5±0.3a 22.7±0.2a 22.4±1.2x 23.4±1.3x 23.0±1.0x 23.6±0.1x
Lactose (%) 0.4±0.04a 0.4±0.05a 0.4±0.02a 0.2±0.02b 0.4±0.00x 0.3±0.00x 0.2±0.00x 0.3±0.00x
Galactose (%) 0.03±0.01a 0.05±0.03ab 0.01±0.00a 0.1±0.01b 0.03±0.00xy 0.06±0.00z 0.03±0.00x 0.04±0.00y
Glucose (%) 0.0±0.0a 0.0±0.0a 0.0±0.0a 0.0±0.0a 0.0±0.1x 0.0±0.0x 0.0±0.0x 0.0±0.0x
Lactic acid (%) 1.0±0.01a 1.0±0.02a 0.9±0.03a 1.0±0.06a 0.5±0.00x 0.6±0.00x 0.7±0.00x 0.5±0.00x
Acetic acid (%) 0.04±0.02a 0.05±0.02a 0.01±0.00a 0.04±0.03a 0.0±0.0x 0.01±0.00y 0.01±0.00y 0.01±0.00y
†CTL, control for the single culture batch; BB-12, B. animalis subsp. lactis BB-12 in single culture; RO0ll, L. rhamnosus RO011 in single culture; RO052, L. helveticus
RO052 in single culture; MCO, control cheese for the mixed culture batch; MCI, RO052+BB-12. MC2, RO052+RO011; MC3, RO052+RO011+BB-12.
a, bResults for single culture cheese samples not horizontally connected with the same letter indicate a significant difference (Tukey–Kramer HSD test; P< 0.05).
x, yResults for mixed culture cheese samples not horizontally connected with the same letter indicate a significant difference (Tukey–Kramer HSD test; P<0.05).
*All results are means followed by their standard deviation (SD).
probiotics because of its high fat content and its high buffering
capacity which enhance bacterial survival through the intestinal
track (Dinakar and Mistry, 1994). Some studies report sufficient
survival of probiotic strains in Cheddar cheese (Phillips et al., 2006;
Ong et al., 2007), but others were not as successful (Lynch et al.,
1996; Gardiner et al., 1998) depending on the choice of strains.
Their interaction with the starter, which could have a negative
impact by its metabolic activity (increase in acidity levels, com-
petition for nutrients, production of antagonistic components)
could also impact probiotic strains negatively, but starter cul-
tures can also degrade milk compounds into new nutrients and
lower the oxygen concentration in the environment to the benefit
of probiotics (Heller, 2001; Champagne et al., 2005). Adding the
probiotic strains directly to milk, and not during cheesemaking,
is also known to increase their viability (Fortin et al., 2011). Fur-
thermore, as higher salt concentration is known to be detrimental
to probiotic viability (Fortin et al., 2011), the lower salt content
in our samples, which was often below the targeted 1.5%, could
have contributed to probiotic survival in our study. The ripening
temperature used (4˚C) could also have contributed to the stability
of viable counts (Sanders and Huis in’t Veld, 1999; Heller, 2001;
Champagne et al., 2008).
Results obtained by PMA-qPCR were lower than those obtained
by traditional microbiological methods for the first data point,
indicating that culture media may lack specificity and detect non-
targeted probiotic strains or non-starter lactic acid bacteria natu-
rally found in Cheddar cheese, especially with lower numbers of
viable probiotic cells at the beginning of cheesemaking. However,
the viable counts obtained by PMA-qPCR reached higher levels of
log 10 cfu/g during cheesemaking. As results obtained by molecu-
lar methods are more accurate than those obtained by traditional
microbiological methods, acceptance of PMA-qPCR for viable
bacteria quantification could be helpful for cheese manufacturers
in adjusting inoculation level and reducing production cost, as
less viable cells would actually be required during the cheesemak-
ing process in order to achieve the legislated level of log 9 cfu/30 g
portion during storage. PMA-qPCR quantification for viability
assessment showed greater accuracy for probiotic quantification
in yogurt as well (García-Cayuela et al., 2009). However, although
all primers were designed to be specific to the chosen lactobacilli
and bifidobacterium species, the presence of non-probiotic strains
of the same species in cheese samples (especially L. rhamnosus and
L. helveticus) might augment the quantification of strains with
health benefits.
For all probiotic strains used in our study, there was no sig-
nificant impact of strain interaction on their viable counts with
either quantification method, indicating no ill-effect on viability
when the strains were used together in the Cheddar cheese matrix.
These strains could therefore be combined in a probiotic cheese,
which should widen the health benefits of such a product (Matto
et al., 2006; Oksaharju et al., 2011). A combination of L. rhamnosus
RO011 and L. helveticus RO052 has already been tested in capsule
form, demonstrating their basic synergy (Foster et al., 2011), but
their health benefits in interaction with B. animalis subsp. lactis
BB-12 remain to be studied. The use of multiple probiotic strains
as adjunct could also contribute to accelerated cheese ripening and
enhance flavor through their effect on lactococci as well as through
their own metabolic activity (Ong et al., 2007).
To our knowledge, this study was the first to optimize PMA-
qPCR to monitor probiotic viability in Cheddar cheese. The results
demonstrate that PMA-qPCR is a specific and powerful approach
compared with traditional quantification methods for the three
probiotic species as well as for lactococci in cheese. The technique
can be used with mixtures of species and provides an accurate
estimation of viability in cheese. This approach could now be used
to further assess bacterial survival in other types of cheese and to
determine the impact of probiotic strain interactions on such food
matrices.
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